![](https://www.embl.org/about/info/course-and-conference-office/wp-content/uploads/Abeyrathne.jpg)
Priyanka Abeyrathne
GlaxoSmithKline Vaccines
USA
EMBL Industry Workshop
Recent technical developments in cryo-electron microscopy (cryo-EM) and cryo-tomography now allow structures of challenging targets relevant for the pharmaceutical industry (membrane proteins, multi-subunit complexes, chromatin complexes etc.) to be determined at unprecedented resolution. This workshop is aimed at members of the pharmaceutical and allied industrial sectors that use (or are considering using) cryo-EM in drug discovery and agricultural research, academic researchers interested in the impact of state-of-the-art cryo-EM in drug discovery, and cryo-EM support staff that want to learn more about the specific needs of industry.
Structural biologists from leading pharmaceutical companies and academia have joined forces to co-organise a science-driven meeting to exchange trends, ideas, use-cases, opportunities and challenges related to the use of cryo-EM in industry and academia.
GlaxoSmithKline Vaccines
USA
MRC Laboratory of Molecular Biology
UK
CNB-CSIC
Spain
Genentech
USA
University of Birmingham
UK
University of Tokyo
Japan
University of Oxford
UK
EMD Serono
USA
EMBL Heidelberg
Germany
Max Planck Institute of Biophysics
Germany
Walter and Eliza Hall Institute of Medical Research
Australia
EMBL Hamburg
Germany
EMBL Heidelberg
Germany
AstraZeneca
UK
University of Leeds
UK
Thermo Fisher Scientific
UK
Monash University
Australia
MRC Laboratory of Molecular Biology
UK
TTP Labtech Limited
UK
Novartis
Switzerland
Diamond Light Source Ltd
UK
GlaxoSmithKline
UK
Sanofi
Germany
EMBL Heidelberg
Germany
Merck
Germany
EMBL Heidelberg
Germany
EMBL Heidelberg
Germany
EMBL Heidelberg
Germany